AL
ABBV icon

Arnhold LLC’s AbbVie ABBV Stock Holding History

Arnhold LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-92,490
Closed -$12.5M – 137
2021
Q4 		$12.5M Sell
92,490
-42,575
-32% -$5.03M 1.42% 29
2021
Q3 		$14.6M Sell
135,065
-35,707
-21% -$4.08M 1.68% 21
2021
Q2 		$19.2M Sell
170,772
-49,576
-22% -$5.58M 2.18% 12
2021
Q1 		$23.8M Sell
220,348
-17,500
-7% -$1.87M 2.86% 3
2020
Q4 		$25.5M Buy
237,848
+60,976
+34% +$5.86M 3.3% 3
2020
Q3 		$15.5M Hold
176,872
– – 2.29% 8
2020
Q2 		$17.4M Buy
176,872
+51,731
+41% +$4.55M 2.76% 5
2020
Q1 		$9.53M Buy
125,141
+46,418
+59% +$3.95M 1.76% 18
2019
Q4 		$6.97M Sell
78,723
-10,413
-12% -$864K 1.1% 36
2019
Q3 		$6.75M Buy
89,136
+15,193
+21% +$1.04M 1.15% 29
2019
Q2 		$5.38M Buy
+73,943
New +$5.81M 0.94% 35

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arnhold LLC's ABBV Position: Q1 2022 in Review

Arnhold LLC sold out of AbbVie (ABBV) in Q1 2022, closing a stake of 92,490 shares — an estimated $12.5M sold.

Arnhold LLC first reported a position in ABBV in Q2 2019 and held it in 11 quarters. The position peaked at $25.5M in Q4 2020. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.

  • Arnhold LLC reported no remaining AbbVie position as of Q1 2022 after selling out during the quarter.
  • Arnhold LLC sold 92,490 AbbVie shares in Q1 2022, an estimated $12.5M.
  • Arnhold LLC first reported a position in AbbVie in Q2 2019 and held it in 11 quarters.
  • Arnhold LLC's AbbVie position peaked at $25.5M in Q4 2020.
  • 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.

Based on Arnhold LLC's 13F filing for Q1 2022, filed 10 May 2022.